This inventor holds 1 USPTO granted patent. Top assignee: Wakamoto Pharmaceutical Co., Ltd.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Masamichi Satomi: Innovator in Medical Diagnostics
Introduction
Masamichi Satomi is a notable inventor based in Nishinomiya, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the diagnosis of Crohn's disease. His innovative approach has led to the development of a unique method and test kit that aids in the detection of this complex condition.
Latest Patents
Masamichi Satomi holds a patent for a method and test kit for measuring immunoglobulins reactive with amylase as an indication of Crohn's disease. This patent describes a method for diagnosing Crohn's disease by detecting the presence of immunoglobulins that react with amylase in a specimen. The method employs immunologic or enzymologic techniques using amylase, along with a test kit designed for this purpose. He has 1 patent to his name.
Career Highlights
Satomi is associated with Wakamoto Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in medical diagnostics. His work has not only contributed to the understanding of Crohn's disease but has also paved the way for improved diagnostic tools in the medical field.
Collaborations
Masamichi Satomi has collaborated with notable colleagues, including Takashi Shimoyama and Tatsuo Tozawa. Their combined expertise has further enhanced the research and development efforts at Wakamoto Pharmaceutical Co., Ltd.
Conclusion
Masamichi Satomi's innovative contributions to medical diagnostics exemplify the impact of dedicated research in improving healthcare outcomes. His work continues to influence the field and offers hope for better diagnostic methods for Crohn's disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
